Last reviewed · How we verify

NCT05097885: VIBE-Rx

Health Benefits of Whole-body Vibration

Recruiting now NA Last updated 28 January 2025
What this trial tests

NA trial testing Sub Acute Whole Body Vibration Training in Whole-body Vibration in 40 participants. Currently enrolling.

Timeline
28 February 2022
Primary endpoint
1 January 2027
1 January 2028

Quick facts

Lead sponsorAugusta University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date28 February 2022
Primary completion1 January 2027
Estimated completion1 January 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Augusta University

Who can join

18 and older, any sex, with Whole-body Vibration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sub Acute Whole Body Vibration Training

Trials testing the same drug.

Other Augusta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05097885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing